HPV vaccination and colposcopy workload of screening programmes

Vaccine

Volumn 26, Issue 52, 2008, Pages 6743-6744

  Zorzi, Manuel ^a   Giorgi Rossi, Paolo ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Agency for Public Health   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLPOSCOPY; HEALTH PROGRAM; HUMAN; LABORATORY DIAGNOSIS; LETTER; PAPANICOLAOU TEST; PATIENT REFERRAL; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS; WORKLOAD;

COLPOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREDICTIVE VALUE OF TESTS; VAGINAL SMEARS; WORKLOAD;

EID: 56949100644     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.007     Document Type: Letter

References (6)

1. Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.H., et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26 (2008) K29-K41 10.1016/j.vaccine.2008.06.019
2. Ault K.A. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369 9576 (2007) 1861-1868
3. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl. 3 (2006) S26-34
4. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97 (2005) 1072-1079
5. Winer R.L., Kiviat N.B., Hughes J.P., Adam D.E., Lee S.K., Kuypers J.M., et al. Development and duration of human papillomavirus lesions after initial infection. J Infect Dis 191 (2005) 731-738
6. EMEA. Gardasil European Public Assessment Report. Scientific Discussion. Available on the web, last access (24/9/08). http://www.emea.europa.eu/humandocs/PDFs/EPAR/gardasil/070306en6.pdf.